This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For wonky-tech readers, this involves using Seqster’s proprietary technology (FHIR+) to enable the flow of patient information from once-siloed data locked into legacy systems and wearable tech clouds.
App Orchard, for its part, lets developers use a FHIR-based API to access an Epic development sandbox. 2018 Digital Health Prediction 2: Voice technology will be the first step to personalising pharma. In Q1 2017 Epic launched a new program App Orchard – serving physician practices and hospitals to help them build customized apps.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers. Comments Comments.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers. Comments Comments.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
Aprima belongs to CommonWell, has done some FHIR development, and Michael would like to see Congress condition Medicare reimbursement on real interoperability. The goal is to compile the most complete patient profile possible, for the benefit of health plans, pharmacy, lifesciences, ACOs, providers.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content